WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding ...
China's WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has ann...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced t...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced const...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that f...
WuXi XDC Cayman Inc. a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on t...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has an...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has kicked off c...
China-based WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has ...
WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO...
China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies ...
China's WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has brok...
WuXi XDC, China-based contract research, development and manufacturing organisation (CRDMO) focused on antibody drug con...
China's WuXi Biologics has signed a research service agreement with Germany-based BioNTech SE, a next generation immunot...
WuXi XDC, a China-based Contract, Research, Development, Manufacturing Organisation (CRDMO) focused on the antibody drug...
WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...
WuXi STA, a global Contract Research, Development, and Manufacturing Organisation (CRDMO), has launched a first high pot...
Pharmadule Morimatsu, a subsidiary of Morimatsu International Holdings, and WuXi Biologics have officially entered ...
China-headquartered WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRD...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO), has...
WuXi STA, a subsidiary of WuXi AppTec, has announced that its first drug product Continuous Manufacturing (CM) line for ...
China-based GeneQuantum Healthcare (GQ) and WuXi XDC, a leading global Contract Research, Development and Manufacturing ...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has launched its...
WuXi Vaccines, a leading global Contract Development and Manufacturing Organisation (CDMO), has entered into an agreemen...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has successfully...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) in China, and Tor...
WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...
China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...
WuXi STA, a subsidiary of China-based WuXi AppTec, has announced the opening of a new large-scale oligonucleotide and pe...
WuXi STA, a WuXi AppTec company, has opened another high-potency API (HPAPI) plant at its Changzhou site (Jiangsu, China...
WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO) service company, has succ...
WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, and A*STAR's Bioprocessing Technology Institute (BTI)...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...
WuXi STA, a subsidiary of WuXi AppTec, has announced that its first parenteral formulation manufacturing line ...
China-based WuXi STA, a subsidiary of WuXi AppTec, and Coherent Biopharma, have announced the signing of a strategic par...
WuXi Biologics has successfully launched the GMP operation of its new drug product facility located in Wuxi, China,...
WuXi STA – a subsidiary of WuXi AppTec – has completed the acquisition of a drug product manufacturing facil...
China based WuXi Biologics, a contract development and manufacturing organization (CDMO) with leading open-access b...
WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it has complete...
From April 21 to 23, the 2021 Taihu Bay Future Healthcare Conference was held in Wuxi, China. More than 1...
WuXi Biologics, a global company with leading open-access biologics technology platforms, has announced that it has ente...
British Columbia-registered BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and...
